EDSA
Edesa Biotech Inc
3.70$
-6.0%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -48.6% | -55.6% | -67.4% | -86.0% | +611.4% | +212.6% | +14.1% | -25.7% | -2.3% | +122.0% | -99.6% | +81,974.0% | -73.7% | +2.5% | -0.5% | -99.5% | +0.0% | -100.0% | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | |
| – | -19.8% | -17.5% | +5.5% | -34.0% | +7.4% | +38.9% | -17.8% | -22.4% | +19.0% | -6.1% | +0.0% | -99.9% | +3,629.9% | +165.7% | -85.3% | +57.2% | +1,146.5% | +3.3% | +4.7% | -7.3% | +2.8% | +0.4% | -1.0% | -2.1% | +0.0% | -5.7% | +204.0% | -44.6% | -2.0% | +0.8% | +13.3% | -14.0% | -2.5% | -43.1% | +5.2% | +0.3% | -1.6% | +1.6% | -0.9% | – | |
| – | -129.7% | – | – | – | – | – | – | – | – | – | -97.2% | +81,953.6% | -74.6% | -3.4% | +8.0% | -101.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -30.3% | -28.5% | +62.8% | +20.7% | -2.5% | -21.7% | -5.8% | +6.9% | -5.4% | -20.1% | +33.9% | -4.2% | +9.6% | -4.8% | +127.5% | +1.0% | +19.5% | +478.1% | -44.0% | -7.5% | -4.3% | -23.0% | +49.5% | -60.6% | -24.3% | +7.4% | -29.7% | -7.0% | -26.1% | +67.0% | -23.7% | -88.4% | +881.8% | -52.5% | +93.9% | +30.5% | -8.2% | +146.0% | +43.0% | – | |
| – | +28.1% | -19.9% | -14.8% | -0.8% | +7.6% | +14.1% | -15.9% | +0.4% | +35.0% | +50.2% | -38.3% | -2.4% | -14.6% | +63.4% | -34.2% | +16.5% | +44.5% | +24.4% | +4.8% | -15.6% | -10.8% | +26.6% | -18.4% | -16.6% | -2.1% | -6.7% | +9.1% | +36.4% | -18.6% | -9.4% | -0.9% | -13.0% | -2.4% | +31.4% | -16.4% | +29.0% | -2.3% | +25.7% | +2.1% | – | |
| – | +0.3% | -22.8% | +8.9% | +9.0% | +2.5% | -3.2% | -12.0% | +3.1% | +17.6% | +25.7% | -22.4% | -3.1% | -5.5% | +33.6% | +16.1% | +7.0% | +30.1% | +263.9% | -36.1% | -10.2% | -5.4% | -11.4% | +26.7% | -51.1% | -16.1% | +1.4% | -14.4% | +12.6% | -22.0% | +22.5% | -13.0% | -50.3% | +97.7% | -13.7% | +16.2% | +28.4% | -5.3% | +84.4% | +29.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +100.0% | +75.0% | +114.3% | +0.0% | -93.3% | – | – | -97.5% | +1,800.0% | -42.3% | +62.9% | -44.0% | +32.3% | -79.8% | -73.3% | -9.3% | -19.0% | +249.4% | +163.8% | -11.1% | -38.8% | +367.4% | +27.9% | +94.1% | +77.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | -5,585.0% | – | – | – | +983.8% | -119.9% | – | – | -3,472.6% | – | -336.2% | – | -431.4% | – | – | – | -96.6% | -884.1% | – | – | – | -2,289.8% | – | – | – | -10,012.9% | – | -100.0% | – | -99.5% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.